How one regulatory protein acts as a multi-tool of bacterial cell wall remodeling.
For bacterial cells to grow and divide, their cell walls need continual remodeling. This process requires a careful balance of lytic enzymes and peptidoglycan production. A team of researchers headed by Martin Thanbichler discovered that a central regulator can control completely different classes of autolysins. Since many antibiotics attack the bacterial cell wall, this discovery could pave the way for new treatment methods against bacterial infections.
During evolution, cells have developed a wide range of strategies to strengthen their envelope against internal osmotic pressure, thus allowing them to grow in a variety of different environments. Most bacterial species synthesize a semi-rigid cell wall surrounding the cytoplasmic membrane, whose main component, peptidoglycan, forms a dense meshwork that encases the cell.
In addition to its protective role, the cell wall also serves as a means to generate specific cell shapes, such as spheres, rods, or spirals, thus facilitating motility, surface colonization, and pathogenicity.
The research team led by Martin Thanbichler, Max Planck Fellow at the Max Planck Institute for Terrestrial Microbiology and Professor of Microbiology at the University of Marburg, has set out to unravel the composition and function of the autolytic machinery. Their studies focus on the crescent-shaped bacterium Caulobacter crescentus, which is found in freshwater environments and widely used as a model organism to study fundamental cellular processes in bacteria.
According to Thanbichler, studying the function of autolysins has been a challenging task. "While we know a lot about the synthetic machinery, the autolysins proved to be a tough nut to crack." Maria Billini, a postdoctoral researcher in Thanbichler's team, adds: "Bacteria usually harbor many types of autolysins from different enzyme families with different targets. This means that these proteins are highly redundant, and the deletion of individual autolysin genes often has little effect on cell morphology and growth."
Versatile regulator
Analysis of potential autolysin regulators by co-immunoprecipitation screening and in vitro protein-protein interaction assays has revealed that a factor called DipM plays a pivotal role in bacterial cell wall remodeling. This key regulator, a soluble periplasmic protein, surprisingly interacts with several classes of autolysins as well as a cell division factor, showing a promiscuity that was previously unknown for this type of regulator.
DipM was able to stimulate the activity of two peptidoglycan-cleaving enzymes with completely different activities and folding, making it the first identified regulator that can control two classes of autolysins. Notably, the results also indicate that DipM uses a single interface to interact with its various targets.
"Disruption of DipM leads to the loss of regulation at various points of the cell wall remodeling and division process and ultimately kills the cell," says doctoral student Adrian Izquierdo Martinez, first author of the study. "Its proper function as a coordinator of autolysin activity is thus critical for proper cell shape maintenance and cell division in C. crescentus."
The comprehensive characterization of DipM revealed a novel interaction network, including a self-reinforcing loop that connects lytic transglycosylases and possibly other autolysins to the core of the cell division apparatus of C. crescentus, and very likely also other bacteria. Thus, DipM coordinates a complex autolysin network whose topology greatly differs from that of previously studied autolysin systems. Martin Thanbichler points out: "The study of such multi-enzyme regulators, whose malfunction affects several cell wall-related processes at the same time, not only helps us to understand how the cell wall responds to changes in the cell or the environment. It can also contribute to the development of new therapeutic strategies that combat bacteria by disrupting several autolytic pathways simultaneously."
Reference: "DipM controls multiple autolysins and mediates a regulatory feedback loop promoting cell constriction in Caulobacter crescentus" by Adrian Izquierdo-Martinez, Maria Billini, Vega Miguel-Ruano, Rogelio Hernández-Tamayo, Pia Richter, Jacob Biboy, María T. Batuecas, Timo Glatter, Waldemar Vollmer, Peter L. Graumann, Juan A. Hermoso, and Martin Thanbichler, 11 July 2023, Nature Communications.
DOI: 10.1038/s41467-023-39783-w
News
Bowel and Ovarian Cancers Are Dramatically Rising in Young Adults, Scientists Aren’t Sure Why
Cancer incidence is increasing, especially among younger adults, and current risk factors don’t fully account for the trend. Scientists suggest other underlying causes may be contributing. Cancer patterns in England are shifting in a [...]
New Immune Pathway Could Supercharge mRNA Cancer Vaccines
A surprising backup system in the immune response to mRNA vaccines may hold the key to more effective cancer treatments. The arrival of mRNA vaccines against SARS-CoV-2 in 2020 marked a turning point in the COVID-19 pandemic. Today, [...]
Scientists Discover “Molecular Switch” That Fuels Alzheimer’s Brain Inflammation
A newly identified trigger of brain inflammation could offer a fresh target for slowing Alzheimer’s progression. The brain has its own built-in immune system that identifies threats and responds to them. In Alzheimer’s disease, growing evidence [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
Forgotten Medicinal Plant Shows Promise in Fighting Dangerous Superbugs
A traditional medicinal plant, tormentil, shows promise against antibiotic-resistant bacteria in laboratory tests. Its compounds work by limiting bacterial growth and boosting antibiotic performance. Before the development of modern antibiotics, plant-based remedies were commonly [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New Research Finds Shocking Link Between Chili Peppers and Cancer
If you love spicy food, you are not alone. But scientists are taking a closer look at whether eating a lot of chili peppers could affect your cancer risk. Could your love of spicy [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
Scientists Create “Neurobots” – Living Machines With Their Own Nervous Systems
Neurobots—xenobots with neurons—show self-organized nervous systems and enhanced behaviors, revealing new insights into how biology builds functional structures. In 2020, researchers at Tufts University developed tiny living structures known as xenobots using frog cells. These microscopic organisms [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Amazonian Chocolate Could Become the Next Superfood, Scientists Say
New research into Amazonian cocoa reveals that its value may extend beyond flavor alone. Chocolate from the Amazon is already known worldwide for its distinctive taste, but new research suggests it may offer even [...]
Nanobody repairs misfolded CFTR inside cells, boosting function in cystic fibrosis
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers have succeeded in developing a so-called nanobody that penetrates directly into human cells and can repair the [...]
20-Year Study Finds Daily Multivitamins Don’t Extend Lifespan
A large, decades-long study of over 390,000 U.S. adults challenges a widespread assumption about daily multivitamins. Multivitamins are a daily habit for millions of Americans, often taken with the expectation that they will extend [...]
Novel Investment Paradigms for Regenerative Healthcare Ecosystems
Introduction The transition toward regenerative healthcare ecosystems—anchored in wellness optimization, disease prevention, eradication strategies, and healthy longevity—necessitates a structural reconfiguration of capital architectures, governance models, and incentive design. Regenerative healthcare, by definition, transcends episodic [...]
What If Consciousness Exists Beyond Your Brain
Scientists still don’t know how consciousness emerges from the brain. New ideas suggest it may not emerge at all, but instead be a basic feature of reality. Is consciousness produced by the brain, or [...]
Scientists Discover Way To Treat Lung Cancer and Its Deadly Side Effect Together
A new approach using lipid nanoparticles to deliver genetic material is showing promise in tackling two major challenges in lung cancer at once.Researchers at Oregon State University have designed a new way to tackle two of [...]















